- Home
- STRO vs JSPR Comparison
STRO vs JSPR Comparison
Compare STRO & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- JSPR
- Stock Information
- Founded
- STRO 2003
- JSPR 2018
- Country
- STRO United States
- JSPR United States
- Employees
- STRO N/A
- JSPR N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STRO Health Care
- JSPR Health Care
- Exchange
- STRO Nasdaq
- JSPR Nasdaq
- Market Cap
- STRO 292.6M
- JSPR 323.0M
- IPO Year
- STRO 2018
- JSPR N/A
- Fundamental
- Price
- STRO $2.81
- JSPR $22.40
- Analyst Decision
- STRO Strong Buy
- JSPR Strong Buy
- Analyst Count
- STRO 7
- JSPR 11
- Target Price
- STRO $12.14
- JSPR $73.38
- AVG Volume (30 Days)
- STRO 1.0M
- JSPR 211.1K
- Earning Date
- STRO 11-13-2024
- JSPR 11-07-2024
- Dividend Yield
- STRO N/A
- JSPR N/A
- EPS Growth
- STRO N/A
- JSPR N/A
- EPS
- STRO N/A
- JSPR N/A
- Revenue
- STRO $160,955,000.00
- JSPR N/A
- Revenue This Year
- STRO N/A
- JSPR N/A
- Revenue Next Year
- STRO N/A
- JSPR N/A
- P/E Ratio
- STRO N/A
- JSPR N/A
- Revenue Growth
- STRO 230.90
- JSPR N/A
- 52 Week Low
- STRO $2.45
- JSPR $4.00
- 52 Week High
- STRO $6.13
- JSPR $31.01
- Technical
- Relative Strength Index (RSI)
- STRO 40.82
- JSPR 51.78
- Support Level
- STRO $2.66
- JSPR $20.73
- Resistance Level
- STRO $2.86
- JSPR $23.89
- Average True Range (ATR)
- STRO 0.17
- JSPR 1.62
- MACD
- STRO 0.03
- JSPR -0.12
- Stochastic Oscillator
- STRO 64.29
- JSPR 46.40
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.